ALZHEIMER'S DRUG OFFERS HOPE: In a significant breakthrough, a newly discovered drug called Donanemab has been hailed as a "turning point" in the battle against Alzheimer's disease. This groundbreaking medication has shown the ability to slow the progression of the disease by up to 35%, allowing individuals with Alzheimer's to maintain their day-to-day tasks such as shopping, housekeeping, managing finances, and medication intake. Donanemab works by targeting and removing the amyloid protein plaques that accumulate in the brains of Alzheimer's patients. For optimal results, these drugs are most effective when administered during the earliest stages of Alzheimer's or even during mild cognitive impairment. While overcoming Alzheimer's is still a long journey ahead, these drugs offer a beacon of hope, bringing renewed optimism to patients and their loved ones in the fight against this devastating condition. (By Sadiq Shaban, Opinion Editor)
Shutterstock